What can initial remdesivir data tell us about tackling COVID-19?
Friday, March 27, 2020 - 15:00
in Health & Medicine
Gilead Sciences' antiviral is in multiple late-stage trials to treat coronavirus infections. Don't expect a home run, say infectious disease experts